REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Neumologico del Oriente S.A. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto Neumologico del Oriente S.A. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Neumologico del Oriente S.A. is an enterprise in Colombia, with the main office in Bucaramanga. It operates in the Ambulatory Health Care Services industry. The company was established on December 16, 1994. 200 (2024) employees currently work for Instituto Neumologico del Oriente S.A.. The company’s latest financial report indicates a net sales revenue increase of 36.86% in 2023. Its total assets grew by 29.64% over the same period. In, 2023, the company’s net profit margin decreased by 2.24%.

Headquarters
Calle 53 # 31 - 30 Barrio Antiguo Campestre
Bucaramanga; Santander;

Contact Details: Purchase the Instituto Neumologico del Oriente S.A. report to view the information.

Website: http://www.ino.com.co

Basic Information
Total Employees:
Purchase the Instituto Neumologico del Oriente S.A. report to view the information.
Outstanding Shares:
Purchase the Instituto Neumologico del Oriente S.A. report to view the information.
Incorporation Date:
December 16, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Neumologico del Oriente S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
36.86%
Total operating revenue
36.86%
Operating profit (EBIT)
25.99%
EBITDA
27.88%
Net Profit (Loss) for the Period
16.69%
Total assets
29.64%
Total equity
33.39%
Operating Profit Margin (ROS)
-2.01%
Net Profit Margin
-2.24%
Return on Equity (ROE)
-4.73%
Debt to Equity Ratio
-6.34%
Quick Ratio
0.15%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?